Stansberry Venture Technology
In Stansberry Venture Technology, Dave Lashmet scours the public markets for little-known, small-cap companies that are producing the next wonder drug or technology. And you can access these opportunities even if you’re not a millionaire or a venture capitalist.
Dave is the perfect man to head up this effort…
He is extremely plugged in to the technology and biotech sector. He’s an inventor with three active patents. He has developed, packaged, and sold his ideas to one of the largest consumer-electronics firms in the world.
He has also spent the last 20-plus years working as an independent technology analyst, and close to a decade researching and writing about technology at five major universities.
In Stansberry Venture Technology, Dave searches for the smallest and most promising firms out there… ones you’d likely never hear about (that is, until they get acquired).
The goal is for subscribers to make five or 10 times their money on these speculations.
Meet Your Editor
Dave Lashmet is editor of Stansberry Venture Technology, an advisory service focused on the most important trend in the world – emerging technologies. He takes a "venture capitalist" approach to investing… seeking out small-cap speculative stocks with strong catalysts and outstanding breakout growth potential.
Dave undertakes intensive research to discover under-the-radar technology and medical companies with stunning catalysts for near-term growth. The stocks recommended in Stansberry Venture Technology have the potential to double and triple in price.
Publication Snapshot
| Editor | Dave Lashmet |
| Investment Goal | Aggressive Growth |
| Safety Profile | Speculative |
| Primary Assets | Stocks |
| Largest Open Gain Return as of 9/18/25 | +448% |
| Years in publication | 11 years |
Call our Baltimore-based Member Services team for full publication details, including your exclusive discounts:
1-800-671-2903
Interested in the most savings?
Consider a 60-day Alliance Membership trial…
The Stansberry Alliance is a way for you to become a “Partner” in Stansberry Research while receiving an eternal stake in our research. Instead of paying for our research year after year – you’ll receive every book, report, and research advisory we publish today and in the future – indefinitely… including Stansberry Venture Technology and Stansberry Venture Value.
If you decide to enroll, you’ll receive a credit for every dollar you’ve spent on our research.
Book a Free Alliance Enrollment Consulation Call